Hidekazu Segawa
- Oncology top 5%
- Molecular Biology
- Hematology top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Taira MaekawaShinya KimuraTakeshi YuasaJunya KurodaMasaki NogawaAsumi YokotaKiyoshi SatoSeiji Matsumoto
- Topics
- Bone health and treatments (8 papers)Chronic Myeloid Leukemia Treatments (7 papers)Radiopharmaceutical Chemistry and Applications (4 papers)
- Cited by
- HematologyOncologyGenetics
In The Last Decade
Hidekazu Segawa
20 papers receiving 957 citations
Peers
Comparison fields: 5 of 71
- Oncology 458
- Molecular Biology 317
- Hematology 233
- Radiology, Nuclear Medicine and Imaging 180
- Pulmonary and Respiratory Medicine 175
Countries citing papers authored by Hidekazu Segawa
This map shows the geographic impact of Hidekazu Segawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidekazu Segawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidekazu Segawa more than expected).
Fields of papers citing papers by Hidekazu Segawa
This network shows the impact of papers produced by Hidekazu Segawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidekazu Segawa. The network helps show where Hidekazu Segawa may publish in the future.
Co-authorship network of co-authors of Hidekazu Segawa
This figure shows the co-authorship network connecting the top 25 collaborators of Hidekazu Segawa. A scholar is included among the top collaborators of Hidekazu Segawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidekazu Segawa. Hidekazu Segawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 165 | |
| 3 | 15 | |
| 4 | 21 | |
| 5 | 20 | |
| 6 | 25 | |
| 7 | 122 | |
| 8 | 7 | |
| 9 | A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo. | 26 |
| 10 | 198 | |
| 11 | 23 | |
| 12 | 49 | |
| 13 | 27 | |
| 14 | 73 | |
| 15 | 45 | |
| 16 | 111 | |
| 17 | 33 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 13 |
About Hidekazu Segawa
Hidekazu Segawa is a scholar working on Hematology, Oncology and Genetics, having authored 20 papers that have together received 985 indexed citations. Recurring topics across this work include Bone health and treatments (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Hematology (233 citations), Oncology (458 citations) and Genetics (145 citations). Hidekazu Segawa has collaborated with scholars based in Japan, Germany and Brazil. Frequent co-authors include Taira Maekawa, Shinya Kimura, Takeshi Yuasa, Junya Kuroda, Masaki Nogawa, Asumi Yokota, Kiyoshi Sato, Seiji Matsumoto, Hiromi Wada and Yuri Kamitsuji. Their work appears in journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.